JoVE Logo
Faculty Resource Center

Sign In

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

DOI :

10.3791/50070-v

9:29 min

February 1st, 2013

February 1st, 2013

17,908 Views

1Division of Pediatrics, U.T. MD Anderson Cancer Center, 2Department of Stem Cell Transplantation and Cellular Therapy, U.T. MD Anderson Cancer Center

T cells expressing a CD19-specific chimeric antigen receptor (CAR) are infused as investigational treatment of B-cell malignancies in our first-in-human gene therapy trials. We describe genetic modification of T cells using the Sleeping Beauty (SB) system to introduce CD19-specific CAR and selective propagation on designer CD19+ artificial antigen presenting cells.

Tags

Sleeping Beauty

-- Views

Related Videos

article

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

article

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate

article

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

article

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells

article

Isolation of Precursor B-cell Subsets from Umbilical Cord Blood

article

Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells

article

Generation of Human Alloantigen-specific T Cells from Peripheral Blood

article

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

article

Highly Multiplexed, Super-resolution Imaging of T Cells Using madSTORM

article

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved